Genus (LON:GNS) Price Target Raised to GBX 2,900

Genus (LON:GNS) had its price objective raised by Deutsche Bank Aktiengesellschaft from GBX 2,550 to GBX 2,900 in a research report report published on Monday morning, Marketbeat reports. The brokerage currently has a buy rating on the stock.

Separately, Shore Capital reaffirmed a “buy” rating and issued a GBX 2,900 price target on shares of Genus in a report on Thursday, September 4th. Two analysts have rated the stock with a Buy rating, According to MarketBeat.com, the stock currently has a consensus rating of “Buy” and an average target price of GBX 2,900.

Genus Price Performance

LON:GNS opened at GBX 2,525 on Monday. Genus has a one year low of GBX 1,424 and a one year high of GBX 3,228.80. The company has a debt-to-equity ratio of 53.12, a quick ratio of 1.08 and a current ratio of 1.80. The stock has a market cap of £1.66 billion, a PE ratio of -40,725.81, a P/E/G ratio of 2.87 and a beta of 0.37. The stock has a 50 day moving average price of GBX 2,533.06 and a 200 day moving average price of GBX 2,127.70.

Genus (LON:GNS) last posted its quarterly earnings results on Thursday, September 4th. The company reported GBX 81.80 EPS for the quarter. Genus had a return on equity of 1.41% and a net margin of 1.18%. Equities research analysts expect that Genus will post 70.9644323 EPS for the current fiscal year.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand.